CANCER BIOL MED - Cancer Biology & Medicine

Publications

  1. 2021
  2. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer

    Marx, A., Koopmann, L., Höflmayer, D., Büscheck, F., Hube-Magg, C., Steurer, S., Eichenauer, T., Clauditz, T. S., Wilczak, W., Simon, R., Sauter, G., Izbicki, J. R., Huland, H., Heinzer, H., Graefen, M., Haese, A., Schlomm, T., Bernreuther, C., Lebok, P. & Bonk, S., 15.02.2021, In: CANCER BIOL MED. 18, 1, p. 245-255 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2019
  4. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

    Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., Tsourlakis, M. C., Minner, S., Simon, R., Sauter, G., Büscheck, F., Jacobsen, F., Hinsch, A., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Clauditz, T. S., Burandt, E., Wilczak, W. & Höflmayer, D., 05.2019, In: CANCER BIOL MED. 16, 2, p. 319-330 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review